Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A palliative care hotline for multiple sclerosis: A pilot feasibility study.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Optic Neuritis Probably Induced by Isotretinoin.
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Association between pathological and MRI findings in multiple sclerosis.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
A genome-wide association study in progressive multiple sclerosis.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
Alemtuzumab 3-year data show durable effect on MS disability
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Progressive multifocal leukoencephalopathy: new concepts.
Epstein-Barr virus, latitude and multiple sclerosis.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Pages